COVID-19 Vaccine

Vaccine Information for the General Public

Anyone 6 months and older is eligible for a FREE COVID-19 vaccine. 

  • All Virginians are encouraged to get vaccinated to protect themselves, their loved ones, and their communities.
  • Vaccines offer the best form of protection against COVID-19.
  • Getting most Virginians vaccinated is the best way to end the pandemic and get back to normal.

Visit the Arlington County Public Health Division COVID-19 Vaccine Clinic Scheduling page for specific information and details on how to get your vaccine.

Remember, receiving the COVID-19 vaccine is just one part of the effort to reduce the spread of the virus. Even after you are vaccinated, you will still need to practice prevention steps.  

COVID-19 Vaccination Schedule for the General Population (Most People) (last updated 6/24/2022)

The Food and Drug Administration (FDA) maintains a list of all approved and authorized COVID-19 vaccines. Talk to your healthcare provider for additional guidance. The COVID-19 Vaccination Schedule for People Who are Moderately or Severely Immunocompromised is provided in a separate table after the COVID-19 Vaccination Schedule for the General Population (Most People). The CDC maintains a current COVID-19 vaccine schedule for most people and people who are moderately or severely immunocompromised. 

 COVID-19 Vaccination Schedule for the General Population (Most People)
COVID-19 Vaccines* Ages Approved Vaccination Schedule
 mRNA Vaccines:**
Pfizer-BioNTech 6 months-4 years

3 Total Doses

3-dose primary series (3-8 weeks between doses 1 and 2; at least 8 weeks between doses 2 and 3)

A booster dose is not currently recommended

Pfizer-BioNTech (Comirnaty 12+)

 

5-49 years

3 Total Doses

2-dose primary series (3-8 weeks between doses)

A single booster dose is recommended 5 or more months after the primary series

Pfizer-BioNTech (Comirnaty) 50 years and older

4 Total Doses

2-dose primary series (3-8 weeks between doses)

2-dose booster series is recommended:

  • First booster dose is recommended at least 5 months after the primary series
  • Second booster dose is recommended using an mRNA vaccine at least 4 months after the first booster dose
Moderna

6 months-17 years

2 Total Doses

2-dose primary series (4-8 weeks between doses)

A booster dose is not currently recommended

Moderna (Spikevax) 18-49 years

3 Total Doses

2-dose primary series (4-8 weeks between doses)

A single booster dose is recommended at least 5 months after the primary series

Moderna (Spikevax) 50 years and older

4 Total Doses

2-dose primary series (4 weeks between doses)

2-dose booster series is recommended:

  • First booster dose is recommended at least 5 months after the primary series
  • Second booster dose is recommended using an mRNA vaccine at least 4 months after the first booster dose
Anyone unable or unwilling to receive mRNA vaccine
Johnson and Johnson (Janssen)

Viral vector vaccine

18-49 years

2 Total Doses

1-dose primary series

A single booster dose^ is recommended at least 2 months after the primary series

^People ages 18-49 who are not moderately or severely immunocompromised and received a Johnson & Johnson (J&J) primary vaccine and J&J booster dose can get a second booster dose using an mRNA vaccine at least 4 months after their first J&J booster dose.

Johnson and Johnson (Janssen)

 Viral vector vaccine

50 years and older

3 Total Doses

1-dose primary series

2-dose booster series is recommended:

  • First booster dose is recommended at least 2 months after the primary series
  • Second booster dose is recommended using an mRNA vaccine at least 4 months after the first booster dose

* CDC recommends mRNA vaccines (Pfizer and Moderna) over the Johnson & Johnson (J&J)/Janssen COVID-19 vaccine for people aged 18 years and older. Anyone unable or unwilling to receive an mRNA vaccine can request Johnson & Johnson’s COVID-19 vaccine. You may choose which COVID-19 vaccine to receive as your primary series and as a booster dose. Talk to your healthcare provider for additional guidance.

** Some people aged 12 and older, especially males 12 to 39 years of age, may want to consult with their healthcare provider about the interval length between the first and second dose of mRNA vaccine series based on the individual patient's risk and benefit profile. (see CDC guidance for more information)

COVID-19 Vaccination Schedule for People Who are Moderately or Severely Immunocompromised (last updated 6/24/2022)

The Food and Drug Administration (FDA) maintains a list of all approved and authorized COVID-19 vaccines. The Centers for Disease Control and Prevention (CDC) provides vaccination guidance for people who are moderately or severely immunocompromised. Talk to your healthcare provider for additional guidance. The COVID-19 Vaccination Schedule for the General Population (Most People) is provided in a separate table above the COVID-19 Vaccination Schedule for People Who are Moderately or Severely Immunocompromised. The CDC maintains a COVID-19 vaccination schedule for most people and people who are moderately or severely immunocompromised.

COVID-19 Vaccination Schedule for People Who are Moderately or Severely Immunocompromised
COVID-19 Vaccines* Ages Approved Vaccination Schedule
mRNA Vaccines:**
Pfizer-BioNTech 6 months-4 years

3 Total Doses

3-dose primary series (3 weeks between doses 1 and 2; at least 8 weeks between doses 2 and 3)

A booster dose is not currently recommended 
Pfizer-BioNTech 5-11 years

4 Total Doses

3-dose primary series (3 weeks between doses 1 and 2; at least 4 weeks between doses 2 and 3)

A single booster dose recommended at least 3 months after the 3-dose primary series 
Pfizer-BioNTech (Comirnaty) 12 years and older 

5 Total Doses

3-dose primary series (3 weeks between doses 1 and 2; at least 4 weeks between doses 2 and 3)

First booster dose recommended at least 3 months after the 3-dose primary series

Second booster dose recommended using an mRNA vaccine at least 4 months after the first booster dose 
Moderna

 

6 months-17 years

3 Total Doses

3-dose primary series (4 weeks between doses 1 and 2; at least 4 weeks between doses 2 and 3)

A booster dose is not currently recommended  
Moderna (Spikevax) 18 years and older

5 Total Doses

3-dose primary series (4 weeks between doses 1 and 2; at least 4 weeks between doses 2 and 3)

First booster dose recommended at least 3 months after the primary series

Second booster dose recommended using an mRNA vaccine at least 4 months after the first booster dose
Anyone unable or unwilling to receive mRNA vaccine

Johnson and Johnson (Janssen)***

Viral vector vaccine

18 years and older

4 Total Doses***

2-dose primary series is recommended

  • First dose is J&J vaccine
  • Second dose is recommended using an mRNA vaccine 4 weeks after the first J&J dose

First booster shot (preferably mRNA) recommended at least 2 months after second primary dose (mRNA)

Second booster dose recommended using an mRNA vaccine at least 4 months after the first mRNA booster dose
 

CDC recommends mRNA vaccines (Pfizer and Moderna) over the Johnson & Johnson (J&J)/Janssen COVID-19 vaccine for people aged 18 years and older. Anyone unable or unwilling to receive an mRNA vaccine can request Johnson & Johnson’s COVID-19 vaccine. You may choose which COVID-19 vaccine to receive as your primary series and as a booster dose. Talk to your healthcare provider for additional guidance.

** Some people aged 12 and older, especially males 12 to 39 years of age, may want to consult with their healthcare providers about the interval length between the first and second dose of mRNA vaccine series based on the individual patient's risk and benefit profile. (see CDC guidance for more information)

*** CDC provides additional details to assist recipients of Johnson and Johnson (Janssen) to complete the 4-dose regimen.  See Appendix D, Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States for more information.

Additional Resources (lasted updated 6/24/2022)